Absorption of cyclosporine neoral early after liver transplantation : Influence of bile on oral absorptionOLDHAFER, K; HALLER, G. W; KATTNER, A et al.Transplantation proceedings. 1996, Vol 28, Num 4, pp 2237-2238, issn 0041-1345Conference Paper

Conversion to microemulsion cyclosporine in stable renal transplant patients : results after one year : Symposium on new developments in immunosuppressive drugs in the field of renal transplantationNEUMAYER, H.-H; BUDDE, K; FÄRBER, L et al.Clinical nephrology. 1996, Vol 45, Num 5, pp 326-331, issn 0301-0430Article

Substitution of conventional cyclosporin with a new microemulsion formulation in renal transplant patients : results after 1 yearNEUMAYER, H.-H; FÄRBER, L; HALLER, P et al.Nephrology, dialysis, transplantation (Print). 1996, Vol 11, Num 1, pp 165-172, issn 0931-0509Article

Influence of bile on cyclosporin absorption fror microemulsion formulation in primary liver transplant recipientsWINKLER, M; RINGE, B; OLDHAFER, K et al.Transplant international. 1995, Vol 8, Num 4, pp 324-326, issn 0934-0874Article

Clinical experience transfering kidney transplant patients from Sandimmum to Sandimmum Neoral : results after 3 monthsNEUMAYER, H.-H; FÄRBER, L; HALLER, P et al.Clinical nephrology. 1995, Vol 43, pp S27-S32, issn 0301-0430, SUP1Conference Paper

Long-term experience with sandimmun neoral : Results in De novo and stable renal transplant patients after 24-month treatmentKORN, A; FÄRBER, L; MAIBÜCHER, A et al.Transplantation proceedings. 1997, Vol 29, Num 7, pp 2945-2947, issn 0041-1345Conference Paper

Long-term results of conversion from existing to microemulsion formulation of cyclosporineNEUMAYER, H.-H; FÄRBER, L; BUDDE, K et al.Transplantation proceedings. 1996, Vol 28, Num 4, pp 2207-2213, issn 0041-1345Conference Paper

Favourable clinical results of sandimmun-neonral in malabsorbing liver and heart transplant recipientsFÄRBER, L; MAIBÜCHER, A; GEISSLER, F et al.Transplantation proceedings. 1994, Vol 26, Num 5, pp 2988-2993, issn 0041-1345Conference Paper

Increased serum stability and prolonged biological half-life of neocarzinostatin covalently bound to monoclonal antibodiesGOTTSCHALK, U; GARNETT, M. C; WARD, R. K et al.Journal of antibiotics (Tokyo. 1968). 1991, Vol 44, Num 10, pp 1148-1154, issn 0021-8820Article

Comparison of efficacy, safety, and tolerability of Neoral vs Sandimmun in de novo renal transplant patients over 24 months' treatmentABENDROTH, D; BUCHHOLZ, B; LAND, W et al.Transplantation proceedings. 1997, Vol 29, Num 1-2, pp 275-276, issn 0041-1345Conference Paper

Absorption of cyclosporine neoral early after liver transplantation : Is it Possible to abandon intravenous cyclosporine A application ?HALLER, G. W; WINKLER, M; VECHSTEIN, W. O et al.Transplantation proceedings. 1996, Vol 28, Num 4, pp 2239-2240, issn 0041-1345Conference Paper

Successful reconversion from tacrolimus to cyclosporine A neoral in pediatric liver recipientsMELTER, M; RODECK, B; KARDORFF, R et al.Transplantation proceedings. 1996, Vol 28, Num 4, pp 2276-2278, issn 0041-1345Conference Paper

Clinical experience in transferring kidney transplant patients from Sandimmun to Sandimmun Neoral : results after 6 monthsNEUMAYER, H.-H; FÄRBER, L; HALLER, P et al.Transplantation proceedings. 1995, Vol 27, Num 5, pp 2679-2682, issn 0041-1345Conference Paper

A new oral formulation of cyclosporine for early oral immunosuppressive therapy in liver transplant recipientsWINKLER, M; HALLER, G; PICHLMAYR, R et al.Transplantation. 1996, Vol 62, Num 8, pp 1063-1068, issn 0041-1337Article